Investigational Drug LMTX as a Glimmer of Hope for Alzheimer’s in Phase III Trials
According to recently presented study at the Alzheimer’s Association International Conference 2016, researchers have completed the first recorded phase III
Read moreAccording to recently presented study at the Alzheimer’s Association International Conference 2016, researchers have completed the first recorded phase III
Read more